NKGen Biotech, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
NKGen Biotech, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2022 to Q2 2024.
  • NKGen Biotech, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $1.1M, a 11.7% increase year-over-year.
  • NKGen Biotech, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $4.11M.
  • NKGen Biotech, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $4.14M, a 5893% increase from 2022.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $4.11M $1.1M +$115K +11.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-09-12
Q1 2024 $3.99M $1.12M -$141K -11.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-20
Q4 2023 $4.14M $928K Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 $967K +$951K +5944% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $982K Apr 1, 2023 Jun 30, 2023 10-Q 2024-09-12
Q1 2023 $1.26M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-20
Q3 2022 $16K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.